Well they are just going to say the potency data was insufficient (thought I'd just beat them to the punch). But its a far cry from the reasons that they spewed and call themselves "correct" with respect to **why** a CRL would be issued (e.g. supposed issues with the treatment arm vs control arm etc.). jb1987 was probably the only one I would say was close to being "correct" with his call, maybe (devils in the detail, and only mesoblast know the details)... but clearly the rest of them are disingenuous.
Cell Therapy News/Articles, page-17065
-
- There are more pages in this discussion • 756 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |